I am a holder of Li-S shares obtained from the PPK in-specie dividend.
I followed the steps on the Li-S website to fill in an application form starting with the 'Priority Offer' option.
I thought I would have to enter the SRN somewhere (starting with an I) as per my (Issuer sponsored) Li-S Holding Statement so they would know I am a priority holder.
During the process it asked me for a HIN (starting with an X) so I entered the HIN associated with my Commsec account.
My initial thought is the Priority Offer is the same as the Public Offer and there is no priority at all.
I am assuming the Automic registry system is going to cross check this to determine I am an existing (priority) shareholder using only my name and address. They will then add those existing Issuer sponsored holdings to the shares I have applied for and the total shares will appear in the CHESS Commsec account under the HIN. To this end I made sure the application Registration Details were identical to the Issuer sponsored Holding Statement which are identical to the CHESS (HIN) details.
Comments anyone?
- Forums
- ASX - By Stock
- LIS
- IPO - Li-S Energy Limited - 30 August 2021 #
IPO - Li-S Energy Limited - 30 August 2021 #, page-25
-
- There are more pages in this discussion • 476 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LIS (ASX) to my watchlist
|
|||||
Last
12.5¢ |
Change
-0.010(7.41%) |
Mkt cap ! $80.02M |
Open | High | Low | Value | Volume |
13.5¢ | 13.5¢ | 12.5¢ | $34.05K | 262.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 139502 | 12.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
13.0¢ | 216375 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 139502 | 0.125 |
11 | 109213 | 0.120 |
2 | 16194 | 0.115 |
2 | 50000 | 0.110 |
1 | 5000 | 0.105 |
Price($) | Vol. | No. |
---|---|---|
0.130 | 216375 | 2 |
0.135 | 172934 | 6 |
0.140 | 61136 | 5 |
0.145 | 43995 | 2 |
0.150 | 83063 | 3 |
Last trade - 15.40pm 15/07/2024 (20 minute delay) ? |
Featured News
LIS (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online